Pharmacyte Biotech, Inc. · NASDAQ:PMCB
Ayrton Capital LLC reported a 9.90% stake in Pharmacyte Biotech, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Ayrton Capital LLC reported a 9.90% stake in Pharmacyte Biotech, Inc., 774,100 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 774,100
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 9.90% | 774,100 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 9.90% | 774,100 |
| Waqas Khatri | 9.90% | 774,100 |